Keywords: Prostate, CEST & MT, APTDiagnosis of prostate cancer (PCa) remains a challenge since PCa often occurs simultaneously with benign prostatic hyperplasia and has similar nodule appearance on T2-weighted imaging and diffusion weighted imaging. Amide proton transfer weighted (APTw) imaging is an endogenous biomarker to detect proteins and peptides in tissues non-invasively. Results of this study indicate the APTw ratio (rAPTw) values of PCa were significantly higher than those of prostate benign nodules. Therefore, rAPTw value is potentially a promising and valuable non-invasive biomarker in differentiating PCa from benign nodules.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords